STRO logo

Sutro Biopharma, Inc. (STRO)

Profile

Full Name

Sutro Biopharma, Inc.

Ticker

NASDAQ: STRO

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

September 27, 2018

Indexes

Not included

Website

https://www.sutrobio.com

Employees

269

Key Details

Price

$0.90(0.00%)

Market Cap

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$62.04M(-59.64% YoY)

Annual EPS

-$2.96(-66.79% YoY)

PE Ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $0.90
    STRO price is $0.90

    30-Day Relative Volume

    0.62
    STRO 30-day relative volume is 0.62

    Price Performance

    Price Most Recent Change

    0%
    STRO price has remained unchanged on Oct 2, 2025

    Price YTD Change

    -51.09%
    STRO price is down -51.09% since January 1st

    Price 1-Year Change

    -74.5%
    STRO price is down -74.5% year-on-year

    Price 3-Year Change

    -84.46%
    STRO price is down -84.46% over the past 3 years

    Price Range

    Price All-Time High

    $28.30
    STRO price is currently -96.82% below its historical high of $28.30

    Price 3-Year Low

    $0.52
    STRO price is currently +73.08% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market Cap

    $76.30M
    STRO market cap is $76.30 million

    Market Cap 3-Year Change

    -75.88%
    STRO market cap is down -75.88% over the past 3 years

    Market Cap All-Time High

    $1.26B
    STRO market cap is currently -93.94% below its historical high of $1.26 billion

    Market Cap Sector Percentile

    36.62%
    STRO market cap is higher than 36.62% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +2.89%
    STRO shares outstanding is up +2.89% year-on-year

    Shares Outstanding 3-Year Change

    +55.17%
    STRO shares outstanding is up +55.17% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.62
    STRO beta is 1.62

    200-day SMA

    $1.12
    STRO price is currently -19.87% below its 200-day simple moving average

    50-day SMA

    $0.88
    STRO price is currently +2.60% above its 50-day simple moving average

    14-Day RSI

    51.27
    STRO 14-day relative strength index is 51.27

    Volume

    0.62
    STRO 30-day relative volume is 0.62

    ATR

    $0.07
    STRO average true range is $0.07

    10-day Historical Volatility

    53.94%
    STRO 10-day historical volatility is 53.94%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $62.04M
    STRO annual revenue is $62.04 million

    Revenue Analysts Estimate

    $98.69M
    STRO annual revenue is currently -37.13% lower than the consensus analysts' forecast

    Revenue 1-Year Change

    -59.64%
    STRO annual revenue is down -59.64% year-on-year

    Revenue Sector Percentile

    63.71%
    STRO annual revenue is higher than 63.71% of companies in Healthcare sector

    EPS

    EPS

    -$2.96
    STRO annual earnings per share is -$2.96

    EPS Analysts Estimate

    -$1.12
    STRO annual earnings per share is currently +164.34% higher than the consensus analysts' forecast

    EPS 1-Year Change

    -66.79%
    STRO annual earnings per share is down -66.79% year-on-year

    EPS Sector Percentile

    30.3%
    STRO annual earnings per share is higher than 30.3% of companies in Healthcare sector

    Profit

    Gross Profit

    $54.83M
    STRO annual gross profit is $54.83 million

    Gross Margin

    88.37%
    STRO annual gross profit margin is 88.37%

    Operating Profit

    -$238.45M
    STRO annual operating income is -$238.45 million

    Operating Margin

    -384.34%
    STRO annual operating profit margin is -384.34%

    Net Income

    -$227.46M
    STRO annual net profit is -$227.46 million

    Net Margin

    -366.62%
    STRO annual net profit margin is -366.62%

    Expenses

    Total Expenses

    $300.50M
    STRO annual total expenses is $300.50 million

    Operating Expenses

    $300.50M
    STRO annual total operating expenses is $300.50 million

    Cost Of Goods Sold

    $7.22M
    STRO annual cost of goods sold is $7.22 million

    Selling, General & Administrative Expenses

    $48.45M
    STRO annual SG&A is $48.45 million

    Depreciation & Amortization

    $7.22M
    STRO annual D&A is $7.22 million

    Interest Expense

    $0.00
    STRO annual interest expense is $0.00

    Income Tax

    $2.36M
    STRO annual income tax is $2.36 million

    EBIT & EBITDA

    EBIT

    -$194.03M
    STRO annual earnings before interest & taxes is -$194.03 million

    EBITDA

    -$186.81M
    STRO annual EBITDA is -$186.81 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total Assets

    $387.21M
    STRO annual total assets is $387.21 million

    Non Current Assets

    $43.90M
    STRO annual long term assets is $43.90 million

    Current Assets

    $343.31M
    STRO annual total current assets is $343.31 million

    Cash and Cash Equivalents

    $190.30M
    STRO annual cash & cash equivalents is $190.30 million

    Accounts Receivable

    $8.62M
    STRO annual accounts receivable is $8.62 million

    Inventory

    $0.00
    STRO annual inventory is $0.00

    Liabilities

    Total Liabilities

    $342.61M
    STRO annual total liabilities is $342.61 million

    Long Term Liabilities

    $210.71M
    STRO annual total long term liabilities is $210.71 million

    Current Liabilities

    $131.89M
    STRO annual current liabilities is $131.89 million

    Accounts Payable

    $10.47M
    STRO annual accounts payable is $10.47 million

    Debt

    Total Debt

    $203.96M
    STRO annual total debt is $203.96 million

    Total Debt 1-Year Change

    +11.61%
    STRO annual total debt is up +11.61% year-on-year

    Long Term Debt

    $196.48M
    STRO annual long term debt is $196.48 million

    Short Term Debt

    $7.48M
    STRO annual short term debt is $7.48 million

    Equity & Capital

    Shareholders Equity

    $44.60M
    STRO annual stockholders equity is $44.60 million

    Book Value

    $44.60M
    STRO annual book value is $44.60 million

    Retained Earnings

    -$786.87M
    STRO annual retained earnings is -$786.87 million

    Working Capital

    $211.42M
    STRO annual working capital is $211.42 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash From Operations

    -$191.54M
    STRO annual cash from operations is -$191.54 million

    Cash From Operations 1-Year Change

    -71.61%
    STRO annual cash from operations is down -71.61% year-on-year

    Cash From Investing

    $218.51M
    STRO annual cash from investing is $218.51 million

    Cash From Investing 1-Year Change

    +5668.5%
    STRO annual cash from investing is up +5668.5% year-on-year

    Cash From Financing

    $94.05M
    STRO annual cash from financing is $94.05 million

    Cash From Financing 1-Year Change

    -31.62%
    STRO annual cash from financing is down -31.62% year-on-year

    CAPEX

    CAPEX

    $3.10M
    STRO annual capital expenditures is $3.10 million

    CAPEX 1-Year Change

    -28.2%
    STRO annual capital expenditures is down -28.2% year-on-year

    Free Cash Flow

    Free Cash Flow

    -$194.64M
    STRO annual free cash flow is -$194.64 million

    Free Cash Flow 1-Year Change

    -67.89%
    STRO annual free cash flow is down -67.89% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross Margin

    88.37%
    STRO annual gross profit margin is 88.37%

    Operating Margin

    -384.34%
    STRO annual operating profit margin is -384.34%

    Net Margin

    -366.62%
    STRO annual net profit margin is -366.62%

    ROA & ROE

    ROA

    -53.02%
    STRO annual return on assets is -53.02%

    ROE

    -234.19%
    STRO annual return on equity is -234.19%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE Ratio

    -
    STRO price to earnings ratio value is unknown

    PE Ratio Sector Percentile

    -
    STRO price to earnings ratio is unknown

    PB Ratio

    PB Ratio

    -2.38
    STRO price to book ratio is -2.38

    PB Ratio Sector Percentile

    8.44%
    STRO price to book ratio is higher than 8.44% of companies in Healthcare sector

    PS Ratio

    PS Ratio

    0.73
    STRO price to sales ratio is 0.73

    PS Ratio Sector Percentile

    15.14%
    STRO price to sales ratio is higher than 15.14% of companies in Healthcare sector

    Enterprise value

    Enterprise Value

    $90.84M
    STRO enterprise value is $90.84 million

    Enterprise Value Sector Percentile

    44.6%
    STRO enterprise value is higher than 44.6% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -0.56
    STRO EV/EBITDA is -0.56

    EV/EBITDA Sector Percentile

    54.37%
    STRO EV/EBITDA is higher than 54.37% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current Ratio

    2.60
    STRO annual current ratio is 2.60

    Quick Ratio

    2.60
    STRO annual quick ratio is 2.60

    Leverage

    Debt To Equity

    0.00
    STRO annual debt to equity ratio is 0.00

    Interest Coverage Ratio

    -
    STRO annual interest coverage ratio value is unknown

    Risk & Stability

    F-Score

    1
    STRO piotroski f-score is 1

    Altman Z-Score

    -3.55
    STRO altman z-score is -3.55

    Analyst ratings

    Recent major analysts updates

    Aug 12, 25 Wells Fargo
    Equal-Weight
    Jun 16, 25 Piper Sandler
    Overweight
    May 19, 25 B of A Securities
    Underperform
    Apr 29, 25 HC Wainwright & Co.
    Neutral
    Mar 17, 25 HC Wainwright & Co.
    Neutral
    Mar 14, 25 Wedbush
    Neutral
    Mar 14, 25 Citizens Capital Markets
    Market Perform
    Mar 14, 25 B of A Securities
    Underperform
    Dec 11, 24 Wells Fargo
    Equal-Weight
    Dec 11, 24 JMP Securities
    Market Outperform

    Institutional Ownership

    Screeners with STRO included

    Growing Shares Outstanding
    Stocks cheaper than 1 dollar
    US stocks
    Stocks with high beta
    Stocks below SMA 200
    Most recommended stocks
    Best performing stocks last 3 months
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    • What is the ticker symbol for Sutro Biopharma, Inc.?
    • Does Sutro Biopharma, Inc. pay dividends?
    • What sector is Sutro Biopharma, Inc. in?
    • What industry is Sutro Biopharma, Inc. in?
    • What country is Sutro Biopharma, Inc. based in?
    • When did Sutro Biopharma, Inc. go public?
    • Is Sutro Biopharma, Inc. in the S&P 500?
    • Is Sutro Biopharma, Inc. in the NASDAQ 100?
    • Is Sutro Biopharma, Inc. in the Dow Jones?
    • When was Sutro Biopharma, Inc.'s last earnings report?
    • When does Sutro Biopharma, Inc. report earnings?

    What is the ticker symbol for Sutro Biopharma, Inc.?

    The ticker symbol for Sutro Biopharma, Inc. is NASDAQ:STRO

    Does Sutro Biopharma, Inc. pay dividends?

    No, Sutro Biopharma, Inc. does not pay dividends

    What sector is Sutro Biopharma, Inc. in?

    Sutro Biopharma, Inc. is in the Healthcare sector

    What industry is Sutro Biopharma, Inc. in?

    Sutro Biopharma, Inc. is in the Biotechnology industry

    What country is Sutro Biopharma, Inc. based in?

    Sutro Biopharma, Inc. is headquartered in United States

    When did Sutro Biopharma, Inc. go public?

    Sutro Biopharma, Inc.'s initial public offering (IPO) was on September 27, 2018

    Is Sutro Biopharma, Inc. in the S&P 500?

    No, Sutro Biopharma, Inc. is not included in the S&P 500 index

    Is Sutro Biopharma, Inc. in the NASDAQ 100?

    No, Sutro Biopharma, Inc. is not included in the NASDAQ 100 index

    Is Sutro Biopharma, Inc. in the Dow Jones?

    No, Sutro Biopharma, Inc. is not included in the Dow Jones index

    When was Sutro Biopharma, Inc.'s last earnings report?

    Sutro Biopharma, Inc.'s most recent earnings report was on August 11, 2025

    When does Sutro Biopharma, Inc. report earnings?

    The date for Sutro Biopharma, Inc.'s next earnings report has not been announced yet
    On this page